Published in
Impact Journals, Oncotarget, 42(7), p. 67686-67698, 2016
DOI: 10.18632/oncotarget.11891
Links
Tools
Role ofTP53mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy
Journal article published in 2016 by
Silvia Darb-Esfahani,
Carsten Denkert,
Albrecht Stenzinger,
Christoph Salat,
Bruno Sinn,
Christian Schem,
Volker Endris,
Peter Klare,
Wolfgang Schmitt,
Jens-Uwe Blohmer 
,
Wilko Weichert,
Markus Möbs ,
Hans Tesch,
Sherko Kümmel,
Peter Sinn
and other authors.
,
Wilko Weichert,
Markus Möbs ,
Hans Tesch,
Sherko Kümmel,
Peter Sinn
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 